BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32367130)

  • 21. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.
    Annede P; Dumas I; Schernberg A; Tailleur A; Fumagalli I; Bockel S; Mignot F; Kissel M; Deutsch E; Haie-Meder C; Chargari C
    Brachytherapy; 2019; 18(3):370-377. PubMed ID: 30797698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of offline adaptive planning techniques in image-guided brachytherapy of cervical cancer.
    Liu H; Kinard J; Maurer J; Shang Q; Vanderstraeten C; Hayes L; Sintay B; Wiant D
    J Appl Clin Med Phys; 2018 Nov; 19(6):316-322. PubMed ID: 30284370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hybrid (CT/MRI based) vs. MRI only based image-guided brachytherapy in cervical cancer: Dosimetry comparisons and clinical outcome.
    Choong ES; Bownes P; Musunuru HB; Rodda S; Richardson C; Al-Qaisieh B; Swift S; Orton J; Cooper R
    Brachytherapy; 2016; 15(1):40-8. PubMed ID: 26602964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 3-year follow-up study of radiotherapy using computed tomography-based image-guided brachytherapy for cervical cancer.
    Kawashima A; Isohashi F; Mabuchi S; Sawada K; Ueda Y; Kobayashi E; Matsumoto Y; Otani K; Tamari K; Seo Y; Suzuki O; Sumida I; Tomimatsu T; Kimura T; Ogawa K
    J Radiat Res; 2019 Mar; 60(2):264-269. PubMed ID: 30649485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative analysis of intra-fractional variation in CT-based image guided brachytherapy for cervical cancer patients.
    Miyasaka Y; Kadoya N; Ito K; Umezawa R; Kubozono M; Yamamoto T; Nakajima Y; Saito M; Takayama Y; Nemoto K; Iwai T; Jingu K
    Phys Med; 2020 May; 73():164-172. PubMed ID: 32361574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy.
    Rijkmans EC; Nout RA; Rutten IH; Ketelaars M; Neelis KJ; Laman MS; Coen VL; Gaarenstroom KN; Kroep JR; Creutzberg CL
    Gynecol Oncol; 2014 Nov; 135(2):231-8. PubMed ID: 25172763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of CT-based brachytherapy in elderly patients with cervical cancer.
    Kobayashi D; Okonogi N; Wakatsuki M; Miyasaka Y; Kiyohara H; Ohno T; Kato S; Nakano T; Kamada T
    Brachytherapy; 2019; 18(6):771-779. PubMed ID: 31506225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
    Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
    Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcomes in cervical cancer patients treated by FDG-PET/CT-based 3-dimensional planning for the first brachytherapy session.
    Oh D; Huh SJ; Park W; Ju SG; Nam H; Lee JE
    Medicine (Baltimore); 2016 Jun; 95(25):e3895. PubMed ID: 27336876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness analysis of 3D image-guided brachytherapy compared with 2D brachytherapy in the treatment of locally advanced cervical cancer.
    Kim H; Rajagopalan MS; Beriwal S; Huq MS; Smith KJ
    Brachytherapy; 2015; 14(1):29-36. PubMed ID: 25443528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy.
    Liu ZS; Guo J; Zhao YZ; Lin X; Zhang BY; Zhang C; Wang HY; Yu L; Ren XJ; Wang TJ
    Int J Gynecol Cancer; 2017 May; 27(4):768-775. PubMed ID: 28267131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interfractional change of high-risk CTV D90 during image-guided brachytherapy for uterine cervical cancer.
    Ohkubo Y; Ohno T; Noda SE; Kubo N; Nakagawa A; Kawahara M; Abe T; Kiyohara H; Wakatsuki M; Nakano T
    J Radiat Res; 2013 Nov; 54(6):1138-45. PubMed ID: 23732770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-volume histogram analysis of composite EQD2 dose distributions using the central shielding technique in cervical cancer radiotherapy.
    Tamaki T; Noda SE; Ohno T; Kumazaki Y; Kato S; Nakano T
    Brachytherapy; 2016; 15(5):598-606. PubMed ID: 27475482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Image-guided brachytherapy (IGBT) combined with whole pelvic intensity-modulated radiotherapy (WP-IMRT) for locally advanced cervical cancer: a prospective study from Chiang Mai University Hospital, Thailand.
    Tharavichitkul E; Wanwilairat S; Chakrabandhu S; Klunklin P; Onchan W; Tippanya D; Nopnop W; Galalae R; Chitapanarux I
    J Contemp Brachytherapy; 2013 Mar; 5(1):10-6. PubMed ID: 23634150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
    Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
    Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computed tomography-based three-dimensional dosimetry of intracavitary brachytherapy for cervical cancer.
    Wadasaki K; Monzen Y; Kurose T; Okazaki H; Mito M
    Jpn J Radiol; 2010 Dec; 28(10):740-5. PubMed ID: 21191739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcomes with MRI-guided image-based brachytherapy in cervical cancer: An institutional experience.
    Simha V; Rai B; Patel FD; Kapoor R; Sharma SC; Singh OA; Singla V; Dhanireddy B; Ghoshal S
    Brachytherapy; 2018; 17(2):345-351. PubMed ID: 29102740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A retrospective study of small-pelvis radiotherapy plus image-guided brachytherapy in stage I-II non-bulky cervical squamous cell carcinoma.
    Yoshimoto Y; Murata K; Irie D; Ando K; Adachi A; Aoki H; Hirakawa T; Noda SE; Nakano T; Ohno T
    J Radiat Res; 2022 Mar; 63(2):290-295. PubMed ID: 35152292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-volume histogram parameters of high-dose-rate brachytherapy for Stage I-II cervical cancer (≤4cm) arising from a small-sized uterus treated with a point A dose-reduced plan.
    Nakagawa A; Ohno T; Noda SE; Kubo N; Kuwako K; Saitoh J; Nakano T
    J Radiat Res; 2014 Jul; 55(4):788-93. PubMed ID: 24566721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy.
    Susko M; Craciunescu O; Meltsner S; Yang Y; Steffey B; Cai J; Chino J
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1099-105. PubMed ID: 26883564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.